Pennathur Arjun, Abbas Ghulam, Landreneau Rodney J, Luketich James D
The Heart, Lung, and Esophageal Surgery Institute, University of Pittsburgh Medical Center, 200 Lothrop Street, Pittsburgh, PA 15213, USA.
Semin Thorac Cardiovasc Surg. 2008 Winter;20(4):279-84. doi: 10.1053/j.semtcvs.2008.11.003.
Lung cancer is the most common cause of cancer related mortality in the United States. Surgical resection is the standard treatment for stage I non-small cell lung cancer (NSCLC). However, many patients who have resectable cancer may have significant comorbidities precluding surgical resection. Radiofrequency ablation is an emerging modality of treatment and may be applicable in this high-risk group of patients. In this article, we review the principles of radiofrequency ablation, the common devices in use, and the results of treatment for stage I non-small cell lung neoplasm.
肺癌是美国癌症相关死亡的最常见原因。手术切除是I期非小细胞肺癌（NSCLC）的标准治疗方法。然而，许多患有可切除癌症的患者可能有严重的合并症，从而无法进行手术切除。射频消融是一种新兴的治疗方式，可能适用于这类高危患者群体。在本文中，我们回顾了射频消融的原理、常用设备以及I期非小细胞肺肿瘤的治疗结果。
